We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go: Stretch investment: Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Stagedoor is a new generation theatre guide and hassle-free booking platform. It is London's first discovery-led theatre application which makes purchasing theatre tickets easy. Stagedoor is the official application for the Camden Fringe and VAULT Festival, and currently, it's having discussions to bring Stagedoor to the Edinburgh Festival. The user growth of the company has increased and reached 53,000 downloads. Furthermore, it has raised 730K from angel investors & an EU innovation grant. Stagedoor will use the funds raised in growing its user base and in improving its application and website.
days to go: Expired investment: £193,450
MergerLinks is a platform where global dealmakers can connect and identify with transaction counterparts based on their relationships and credentials. The company collates proprietary and public transactions data and assembles it into an information tool. MergerLinks also forms an ecosystem where clients can easily access advisory services. This is done by contacting and identifying people with the right skill set and network. Most of the revenue generated by MergerLinks comes from the sale of B2B subscriptions to a range of connectivity and data tools. With the proceeds, the company will market its premium subscriptions, build the network of content distribution partners, and build Customer Success function.
days to go: Expired investment: £239,270
dooo is an all-inclusive platform that offers on-demand specialised home haircut service to consumers. The company claims that 21% of people reported a disability in the UK in 2018 and 49% of people reported social anxiety or other mental health issues, that prevented them from visiting a salon. dooo wants to change this by helping everyone get the haircut they want, wherever they want and overcome the inequalities in the hair industry. dooo allows users to connect with the stylist beforehand and express any special requests to tailor the experience to their requirements. The company aims to become a contender in the 'Hair & Beauty industry that generated over £8 billion in 2018 in the UK alone. dooo will use the investment to develop native mobile apps on both iOS and Android, boost marketing and PR strategies to further its 'Bristol Launch' in Summer 2021, pay wages to essential staff, and manage administrative tasks.

Pitch Rated

75%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £70,850
Chip is a savings and investment portal. The company has over 250,000 registered users, processed over £165 million in savings, achieved Financial Conduct Authority (FSA) authorisation and launched Financial Services Compensation Scheme (FSCS) eligible interest accounts with market-leading rates. It aims to be the go to investment platform for the mobile generation that consists of 100 million customers and 30 trillion assets across Europe. Chip started with autosaving and seamless access to market-leading saving accounts. With its premium account ChipX, the company is venturing into investment funds, savings accounts, and pensions. It will use the investment to open up its investor community to new and existing investors to participate in this convertible round. It will also initiate discussions with venture capitalists to secure a follow up investment.
days to go: Expired investment: £11,403,860
RiskSave is an online service that makes investment easy and accessible to everyone. As RiskSave do not employ investment advisors their fees are much lower and therefore allowing the client to earn a stronger performance.
days to go: Expired investment: £272,880
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph